evans blue has been researched along with Sciatica in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calignano, A; D'Agostino, G; Iacono, A; La Rana, G; Meli, R; Piomelli, D; Raso, GM; Russo, R; Sasso, O | 1 |
Yonehara, N; Yoshimura, M | 1 |
2 other study(ies) available for evans blue and Sciatica
Article | Year |
---|---|
AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: role for cannabinoid receptors.
Topics: Analgesics; Analysis of Variance; Animals; Arachidonic Acids; Benzoxazines; Capillary Permeability; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Evans Blue; Hyperalgesia; Male; Morpholines; Motor Activity; Naphthalenes; Pain Measurement; Pain Threshold; Plasma; Rats; Rats, Wistar; Reaction Time; Receptors, Cannabinoid; Sciatica | 2008 |
Influence of painful chronic neuropathy on neurogenic inflammation.
Topics: Administration, Topical; Analgesics; Animals; Capsaicin; Chronic Disease; Coloring Agents; Electric Stimulation; Evans Blue; Hot Temperature; Indoles; Isoindoles; Ligation; Male; Nerve Fibers; Neurogenic Inflammation; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Sciatic Nerve; Sciatica; Substance P | 2001 |